Changjiang Pharmaceutical Group Co., Ltd. (SHE:300391)
China flag China · Delayed Price · Currency is CNY
0.9200
+0.1500 (19.48%)
At close: Jan 23, 2026

SHE:300391 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
21.748.315.217.47107.7139.42
Trading Asset Securities
-----0.5
Cash & Short-Term Investments
21.748.315.217.47107.7139.92
Cash Growth
222.79%-45.43%-13.00%-83.77%-23.03%-65.81%
Accounts Receivable
908.61985.371,6461,4471,5231,435
Other Receivables
52.2170.27254.3431.4252.72163.19
Receivables
960.821,0561,9011,4791,5761,598
Inventory
85.7442.4551.8659.47195.35251.61
Prepaid Expenses
--0.02---
Other Current Assets
23.9922.97160.79185.85180.31129.21
Total Current Assets
1,0921,1292,1291,7422,0592,119
Property, Plant & Equipment
611.89634.73962.391,0781,3061,162
Goodwill
16.3716.37236.07675.43701.73701.73
Other Intangible Assets
75.9477.5199.1841.7462.6772.88
Long-Term Accounts Receivable
--2.21---
Long-Term Deferred Tax Assets
--16.4739.866.2252.96
Long-Term Deferred Charges
127.1137.72-0.3613.3515.36
Other Long-Term Assets
-0.030.811.695.08559.13
Total Assets
1,9241,9963,4463,5794,2144,683
Accounts Payable
234.61223.27358.51199.55642.86604.2
Accrued Expenses
24.37165.54138.08116.79135.38117.16
Short-Term Debt
207.95656.69587.3607.37586.06537.69
Current Portion of Long-Term Debt
56.594.147846.421.91114.5
Current Portion of Leases
-0.9430.0324.029.44-
Current Income Taxes Payable
124.1340.0540.2140.2444.0732.3
Current Unearned Revenue
18.0223.0916.9514.4813.2728.11
Other Current Liabilities
1,534720.91631.34496.21656.931,193
Total Current Liabilities
2,2001,9251,8801,5452,1102,627
Long-Term Debt
375.25444.4518.89335.83312.49340
Long-Term Leases
-1.395.455.9721.15-
Long-Term Unearned Revenue
14.7214.9615.8915.923.7126.08
Long-Term Deferred Tax Liabilities
1.181.67.17.18.7110.95
Other Long-Term Liabilities
0.1130.080.684.1129.2229.6
Total Liabilities
2,5912,4172,4281,9142,6053,234
Common Stock
350.34350.34350.34350.34350.34350.34
Additional Paid-In Capital
788.17788.17788.17788.07790.05790.05
Retained Earnings
-1,781-1,571-943.39-337.73-314.46-363.57
Comprehensive Income & Other
----0.36-0.13
Total Common Equity
-642.57-432.84195.12800.67826.28776.69
Minority Interest
-25.0411.49822.2863.95783.01672.79
Shareholders' Equity
-667.62-421.361,0171,6651,6091,449
Total Liabilities & Equity
1,9241,9963,4463,5794,2144,683
Total Debt
639.691,1981,2201,020951.04992.19
Net Cash (Debt)
-617.95-1,189-1,204-1,002-843.34-852.27
Net Cash Per Share
-1.76-3.39-3.44-2.86-2.41-2.43
Filing Date Shares Outstanding
350.34350.34350.34350.34350.34350.34
Total Common Shares Outstanding
350.34350.34350.34350.34350.34350.34
Working Capital
-1,108-795.29248.2196.6-50.96-508.19
Book Value Per Share
-1.83-1.240.562.292.362.22
Tangible Book Value
-734.89-526.72-140.1383.561.882.08
Tangible Book Value Per Share
-2.10-1.50-0.400.240.180.01
Buildings
-779.09895.16990.621,063488.18
Machinery
-114.09101.3693.78302.2296.27
Construction In Progress
--184.82177.94170.31591.23
Source: S&P Global Market Intelligence. Standard template. Financial Sources.